AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER
Sep 162014
 

 

 

An automated flow-based synthesis of imatinib: the API of gleevec 

M.D. Hopkin, I.R. Baxendale, S.V. Ley, J.C.S. Chem. Commun.2010, 46, 2450-2452.

http://pubs.rsc.org/en/Content/ArticleLanding/2010/CC/c001550d#!divAbstract

A concise, flow-based synthesis of Imatinib, a compound used for the treatment of chronic myeloid leukaemia, is described whereby all steps are conducted in tubular flow coils or cartridges packed with reagents or scavengers to effect clean product formation.

An in-linesolvent switching procedure was developed enabling the procedure to be performed with limited manual handling of intermediates.

Graphical abstract: A flow-based synthesis of Imatinib: the API of Gleevec

 

see supp info

http://www.rsc.org/suppdata/cc/c0/c001550d/c001550d.pdf

 

Share

  2 Responses to “An automated flow-based synthesis of imatinib: the API of gleevec”

  1. Most Facebook users are teenagers who do not have a
    lot of money to spend. The following are four prime reasons why you should be using Pinterest,
    including examples of practical applications:. I make boards of animals, quotes, or color combinations.

  2. […] drug news and synthetic developments in the field. He has added additional information in All About Drugs related to synthetic flow examples as well. The link to Steve Ley’s report on a flow process […]

Sorry, the comment form is closed at this time.

Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: